Filing Details

Accession Number:
0000937556-17-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-27 17:36:25
Reporting Period:
2017-01-25
Filing Date:
2017-01-27
Accepted Time:
2017-01-27 17:36:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442689 Jon Coleman C/O Masimo Corporation
52 Discovery
Irvine CA 92618
Pres-Ww Sales,Pro Svc,Med Affs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-25 1,525 $24.68 8,707 No 4 M Direct
Common Stock Disposition 2017-01-25 1,525 $72.50 7,182 No 4 S Direct
Common Stock Acquisiton 2017-01-27 4,275 $24.68 11,457 No 4 M Direct
Common Stock Disposition 2017-01-27 4,275 $72.50 7,182 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2017-01-25 1,525 $24.68 1,525 $24.68
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2017-01-27 4,275 $24.68 4,275 $24.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,578 2010-08-17 2019-08-17 No 4 M Direct
17,303 2010-08-17 2019-08-17 No 4 M Direct
Footnotes
  1. The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 7, 2016, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on August 17, 2009 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary date.